Petrie Dish

Millions of Americans are suffering from undiagnosed illnesses. Many are told their symptoms are imagined. Could artificial intelligence change the game, figuring out how to diagnose rare and difficult to diagnose diseases, leading to better understanding of their causes and better treatments? One San Antonio researcher thinks so.

A new medication to treat schizophrenia has been developed by scientists who discovered that a neuron that inhibits the activity of other cells may be in short supply in those with the disorder.

The World Health Organization is again warning the world about mpox, declaring an outbreak in central Africa.

UT Health San Antonio Speech-Language Pathology program graduate students are helping local kids at risk for developing a language disorder through a program called LAUNCH. Angela Kennedy, SLP-D, CCC-SLP, is the director of clinical education and an assistant professor for the Speech-Language Pathology program in the Department of Communication Sciences and Disorders.

A digital tool that uses artificial intelligence to analyze speech patterns could help doctors detect dementia in patients when other signs and symptoms are not perceptible.

Up to two percent of Texans have epilepsy. Dr. Charles Szabo at UT Health San Antonio has developed an epilepsy surgery program and is leading groundbreaking research and clinical trials that offer hope to those with the seizure disorder who don't respond to existing medications.

People who eat a strict keto diet are at risk for an accumulation of aged cells in their organs, but taking intermittent breaks from the diet can prevent these detrimental effects.

Adam Salmon, PhD, studies aging in marmosets. He and his team recently concluded that an immunosuppressant called rapamycin extends the lifespan of marmosets. This has significant implications for the study of aging in humans.

At the scene of an emergency, a flurry of decisions must be made. A new AI tool called the iRemedyAct could expedite processes of care during health emergencies.

David Morilak, PhD, a professor of pharmacology and director of the Center for Biomedical Neuroscience at UT Health San Antonio, studies rats in an effort to understand the characteristics of stressful events that can lead to PTSD in humans.